2247 related articles for article (PubMed ID: 33871358)
1. Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.
Onur TS; Laitman A; Zhao H; Keyho R; Kim H; Wang J; Mair M; Wang H; Li L; Perez A; de Haro M; Wan YW; Allen G; Lu B; Al-Ramahi I; Liu Z; Botas J
Elife; 2021 Apr; 10():. PubMed ID: 33871358
[TBL] [Abstract][Full Text] [Related]
2. Impairment of the Glial Phagolysosomal System Drives Prion-Like Propagation in a
Davis GH; Zaya A; Pearce MMP
J Neurosci; 2024 May; 44(20):. PubMed ID: 38589228
[TBL] [Abstract][Full Text] [Related]
3. Frequency of nuclear mutant huntingtin inclusion formation in neurons and glia is cell-type-specific.
Jansen AH; van Hal M; Op den Kelder IC; Meier RT; de Ruiter AA; Schut MH; Smith DL; Grit C; Brouwer N; Kamphuis W; Boddeke HW; den Dunnen WF; van Roon WM; Bates GP; Hol EM; Reits EA
Glia; 2017 Jan; 65(1):50-61. PubMed ID: 27615381
[TBL] [Abstract][Full Text] [Related]
4. Cell-intrinsic glial pathology is conserved across human and murine models of Huntington's disease.
Benraiss A; Mariani JN; Osipovitch M; Cornwell A; Windrem MS; Villanueva CB; Chandler-Militello D; Goldman SA
Cell Rep; 2021 Jul; 36(1):109308. PubMed ID: 34233199
[TBL] [Abstract][Full Text] [Related]
5. Increased energy metabolism rescues glia-induced pathology in a Drosophila model of Huntington's disease.
Besson MT; Dupont P; Fridell YW; Liévens JC
Hum Mol Genet; 2010 Sep; 19(17):3372-82. PubMed ID: 20566711
[TBL] [Abstract][Full Text] [Related]
6. Rab8 Promotes Mutant HTT Aggregation, Reduces Neurodegeneration, and Ameliorates Behavioural Alterations in a Drosophila Model of Huntington's Disease.
Delfino L; Mason RP; Kyriacou CP; Giorgini F; Rosato E
J Huntingtons Dis; 2020; 9(3):253-263. PubMed ID: 33044189
[TBL] [Abstract][Full Text] [Related]
7. Phagocytic glia are obligatory intermediates in transmission of mutant huntingtin aggregates across neuronal synapses.
Donnelly KM; DeLorenzo OR; Zaya AD; Pisano GE; Thu WM; Luo L; Kopito RR; Panning Pearce MM
Elife; 2020 May; 9():. PubMed ID: 32463364
[TBL] [Abstract][Full Text] [Related]
8. AKT-sensitive or insensitive pathways of toxicity in glial cells and neurons in Drosophila models of Huntington's disease.
Liévens JC; Iché M; Laval M; Faivre-Sarrailh C; Birman S
Hum Mol Genet; 2008 Mar; 17(6):882-94. PubMed ID: 18065778
[TBL] [Abstract][Full Text] [Related]
9. Loss-of-Huntingtin in Medial and Lateral Ganglionic Lineages Differentially Disrupts Regional Interneuron and Projection Neuron Subtypes and Promotes Huntington's Disease-Associated Behavioral, Cellular, and Pathological Hallmarks.
Mehler MF; Petronglo JR; Arteaga-Bracho EE; Gulinello ME; Winchester ML; Pichamoorthy N; Young SK; DeJesus CD; Ishtiaq H; Gokhan S; Molero AE
J Neurosci; 2019 Mar; 39(10):1892-1909. PubMed ID: 30626701
[TBL] [Abstract][Full Text] [Related]
10. Targeting ATM ameliorates mutant Huntingtin toxicity in cell and animal models of Huntington's disease.
Lu XH; Mattis VB; Wang N; Al-Ramahi I; van den Berg N; Fratantoni SA; Waldvogel H; Greiner E; Osmand A; Elzein K; Xiao J; Dijkstra S; de Pril R; Vinters HV; Faull R; Signer E; Kwak S; Marugan JJ; Botas J; Fischer DF; Svendsen CN; Munoz-Sanjuan I; Yang XW
Sci Transl Med; 2014 Dec; 6(268):268ra178. PubMed ID: 25540325
[TBL] [Abstract][Full Text] [Related]
11. Astrocytes are key but indirect contributors to the development of the symptomatology and pathophysiology of Huntington's disease.
Meunier C; Merienne N; Jollé C; Déglon N; Pellerin L
Glia; 2016 Nov; 64(11):1841-56. PubMed ID: 27442486
[TBL] [Abstract][Full Text] [Related]
12. The contribution of glial cells to Huntington's disease pathogenesis.
Wilton DK; Stevens B
Neurobiol Dis; 2020 Sep; 143():104963. PubMed ID: 32593752
[TBL] [Abstract][Full Text] [Related]
13. Mutant huntingtin in glial cells exacerbates neurological symptoms of Huntington disease mice.
Bradford J; Shin JY; Roberts M; Wang CE; Sheng G; Li S; Li XJ
J Biol Chem; 2010 Apr; 285(14):10653-61. PubMed ID: 20145253
[TBL] [Abstract][Full Text] [Related]
14. Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington's disease.
Wang N; Gray M; Lu XH; Cantle JP; Holley SM; Greiner E; Gu X; Shirasaki D; Cepeda C; Li Y; Dong H; Levine MS; Yang XW
Nat Med; 2014 May; 20(5):536-41. PubMed ID: 24784230
[TBL] [Abstract][Full Text] [Related]
15. Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms.
Bradford J; Shin JY; Roberts M; Wang CE; Li XJ; Li S
Proc Natl Acad Sci U S A; 2009 Dec; 106(52):22480-5. PubMed ID: 20018729
[TBL] [Abstract][Full Text] [Related]
16. mHTT Seeding Activity: A Marker of Disease Progression and Neurotoxicity in Models of Huntington's Disease.
Ast A; Buntru A; Schindler F; Hasenkopf R; Schulz A; Brusendorf L; Klockmeier K; Grelle G; McMahon B; Niederlechner H; Jansen I; Diez L; Edel J; Boeddrich A; Franklin SA; Baldo B; Schnoegl S; Kunz S; Purfürst B; Gaertner A; Kampinga HH; Morton AJ; Petersén Å; Kirstein J; Bates GP; Wanker EE
Mol Cell; 2018 Sep; 71(5):675-688.e6. PubMed ID: 30193095
[TBL] [Abstract][Full Text] [Related]
17. Reducing canonical Wingless/Wnt signaling pathway confers protection against mutant Huntingtin toxicity in Drosophila.
Dupont P; Besson MT; Devaux J; Liévens JC
Neurobiol Dis; 2012 Aug; 47(2):237-47. PubMed ID: 22531500
[TBL] [Abstract][Full Text] [Related]
18. Prion-like transmission of neuronal huntingtin aggregates to phagocytic glia in the Drosophila brain.
Pearce MMP; Spartz EJ; Hong W; Luo L; Kopito RR
Nat Commun; 2015 Apr; 6():6768. PubMed ID: 25866135
[TBL] [Abstract][Full Text] [Related]
19. Human ESC-Derived Chimeric Mouse Models of Huntington's Disease Reveal Cell-Intrinsic Defects in Glial Progenitor Cell Differentiation.
Osipovitch M; Asenjo Martinez A; Mariani JN; Cornwell A; Dhaliwal S; Zou L; Chandler-Militello D; Wang S; Li X; Benraiss SJ; Agate R; Lampp A; Benraiss A; Windrem MS; Goldman SA
Cell Stem Cell; 2019 Jan; 24(1):107-122.e7. PubMed ID: 30554964
[TBL] [Abstract][Full Text] [Related]
20. Normalizing glucocorticoid levels attenuates metabolic and neuropathological symptoms in the R6/2 mouse model of huntington's disease.
Dufour BD; McBride JL
Neurobiol Dis; 2019 Jan; 121():214-229. PubMed ID: 30292559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
